Discover 504 paid clinical trials in Memphis, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 504
Active & Responsive
Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)
for
HIV Pre-exposure Prophylaxis
Location: Memphis TN, Birmingham AL, Atlanta GA, New Orleans LA,
Sponsor: Gilead Sciences
Sex: All
Age: 16+
Code: NCT07047716
Phase3, Recruiting
Active & Responsive
Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
for
Friedreich Ataxia
Location: Memphis TN, Atlanta GA, Iowa City IA, Columbus OH,
Sponsor: Friedreich's Ataxia Research Alliance
Sex: All
Age: 0+
Code: NCT06016946
Recruiting
Active & Responsive
Exploring the Physiologic, Pharmacodynamic, and Clinical Responses of Skeletal Muscle in Patients With Spinal Muscular Atrophy Treated With SMN-Directed Therapies
for
Spinal Muscular Atrophy
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 5 - 20
Code: NCT06532474
Recruiting
Active & Responsive
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
for
Acute Myeloid Leukemia
Location: Memphis TN, Little Rock AR, Cincinnati OH, Madison WI,
Sponsor: Norman J. Lacayo
Sex: All
Age: 0 - 21
Code: NCT05101551
Phase1, Recruiting
Active & Responsive
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors
for
ALK Fusion-positive Solid or CNS Tumors
Location: Memphis TN, Cincinnati OH, Ann Arbor MI,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 0 - 17
Code: NCT04774718
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
Location: Memphis TN, Little Rock AR, Nashville TN, Jackson MS,
Sponsor: PedAL BCU, LLC
Sex: All
Age: 0 - 21
Code: NCT05183035
Phase3, Recruiting
Active & Responsive
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
for
Hemophilia B
Location: Memphis TN, Atlanta GA, Gainesville FL, Ann Arbor MI
Sponsor: CSL Behring
Sex: Male
Age: 11 - 17
Code: NCT07080905
Phase3, Recruiting
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
for
Pleuropulmonary Blastoma
Location: Memphis TN, Little Rock AR, Nashville TN, Jackson MS,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT06647953
Phase3, Recruiting
Active & Responsive
Responding With Evidence and Access for Childhood Headaches